A phase II study of radiation with concomitant and then sequential temozolomide in patients with newly diagnosed supratentorial malignant glioma who have undergone surgery with Gliadel wafer [carmustine polifeprosan 20 wafer] insertion

Trial Profile

A phase II study of radiation with concomitant and then sequential temozolomide in patients with newly diagnosed supratentorial malignant glioma who have undergone surgery with Gliadel wafer [carmustine polifeprosan 20 wafer] insertion

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Carmustine polifeprosan 20 wafer; Temozolomide
  • Indications Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Sep 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 30 Oct 2007 Status changed from recruiting to in progress.
    • 22 Nov 2006 11th Annual Meeting of the Society for Neuro-Oncology (SNO).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top